← Back to directory

Matthew Meyerson

Researcher Next ID · RN-019635

Researcher · Biochemistry, Genetics and Molecular Biology

Broad Institute

Cambridge, United States

Not currently recruitingFunding unknown
Works count
1,761
Citation count
279,606
H-index
211
i10-index
450

Research interests

Biochemistry, Genetics and Molecular Biology
Medicine
Immunology and Microbiology
Cancer Genomics and Diagnostics
Lung Cancer Treatments and Mutations
Pancreatic and Hepatic Oncology Research
RNA modifications and cancer
Immunotherapy and Immune Responses

Publications

  • Discovering the anticancer potential of non-oncology drugs by systematic viability profiling

    Nature Cancer · 2020 · https://doi.org/10.1038/s43018-019-0018-6

  • Mutational signature in colorectal cancer caused by genotoxic pks+ E. coli

    Nature · 2020 · https://doi.org/10.1038/s41586-020-2080-8

  • Commensal Microbiota Promote Lung Cancer Development via γδ T Cells

    Cell · 2019 · https://doi.org/10.1016/j.cell.2018.12.040

  • Oncogenic Signaling Pathways in The Cancer Genome Atlas

    Cell · 2018 · https://doi.org/10.1016/j.cell.2018.03.035

  • Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes

    Nature Medicine · 2018 · https://doi.org/10.1038/s41591-018-0016-8

  • Analysis of Fusobacterium persistence and antibiotic response in colorectal cancer

    Science · 2017 · 10.1126/science.aal5240

  • Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer

    Cell · 2017 · 10.1016/j.cell.2017.09.007

  • Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma

    Cell · 2017 · 10.1016/j.cell.2017.05.046

  • Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma

    Cancer Cell · 2017 · 10.1016/j.ccell.2017.07.007

  • Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma

    Cancer Cell · 2016 · 10.1016/j.ccell.2016.04.002

  • Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma

    Cancer Cell · 2016 · 10.1016/j.ccell.2016.04.002

  • Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas

    Nature Genetics · 2016 · 10.1038/ng.3564

  • Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma

    Cell · 2016 · 10.1016/j.cell.2015.12.028

  • Prospective Derivation of a Living Organoid Biobank of Colorectal Cancer Patients

    Cell · 2015 · 10.1016/j.cell.2015.03.053

  • Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets

    Cancer Discovery · 2015 · 10.1158/2159-8290.cd-15-0369

  • Comprehensive molecular characterization of urothelial bladder carcinoma

    Nature · 2014 · 10.1038/nature12965

  • Comprehensive molecular characterization of gastric adenocarcinoma

    Nature · 2014 · 10.1038/nature13480

  • The Somatic Genomic Landscape of Chromophobe Renal Cell Carcinoma

    Cancer Cell · 2014 · 10.1016/j.ccr.2014.07.014

  • Discovery and saturation analysis of cancer genes across 21 tumour types

    Nature · 2014 · 10.1038/nature12912

  • The genetic landscape of high-risk neuroblastoma

    Nature Genetics · 2013 · 10.1038/ng.2529

  • Signatures of mutational processes in human cancer

    Nature · 2013 · https://doi.org/10.1038/nature12477

  • Mutational heterogeneity in cancer and the search for new cancer-associated genes

    Nature · 2013 · 10.1038/nature12213

  • Fusobacterium nucleatum Potentiates Intestinal Tumorigenesis and Modulates the Tumor-Immune Microenvironment

    Cell Host & Microbe · 2013 · 10.1016/j.chom.2013.07.007

  • Pan-cancer patterns of somatic copy number alteration

    Nature Genetics · 2013 · 10.1038/ng.2760

  • Evolution and Impact of Subclonal Mutations in Chronic Lymphocytic Leukemia

    Cell · 2013 · 10.1016/j.cell.2013.01.019

  • Punctuated Evolution of Prostate Cancer Genomes

    Cell · 2013 · 10.1016/j.cell.2013.03.021

  • Absolute quantification of somatic DNA alterations in human cancer

    Nature Biotechnology · 2012 · 10.1038/nbt.2203

  • The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity

    Nature · 2012 · https://doi.org/10.1038/nature11003

  • Prognostically relevant gene signatures of high-grade serous ovarian carcinoma

    Journal of Clinical Investigation · 2012 · 10.1172/jci65833

  • A Landscape of Driver Mutations in Melanoma

    Cell · 2012 · 10.1016/j.cell.2012.06.024

  • Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations

    Nature · 2012 · 10.1038/nature11329

  • Dissecting the genomic complexity underlying medulloblastoma

    Nature · 2012 · 10.1038/nature11284

  • Mapping the Hallmarks of Lung Adenocarcinoma with Massively Parallel Sequencing

    Cell · 2012 · 10.1016/j.cell.2012.08.029

  • Genomic analysis identifies association of Fusobacterium with colorectal carcinoma

    Genome Research · 2011 · 10.1101/gr.126573.111

  • The Mutational Landscape of Head and Neck Squamous Cell Carcinoma

    Science · 2011 · 10.1126/science.1208130

  • Initial genome sequencing and analysis of multiple myeloma

    Nature · 2011 · 10.1038/nature09837

  • The genomic complexity of primary human prostate cancer

    Nature · 2011 · 10.1038/nature09744

  • Integrated genomic analyses of ovarian carcinoma

    Nature · 2011 · https://doi.org/10.1038/nature10166

  • Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1

    Cancer Cell · 2010 · 10.1016/j.ccr.2009.12.020

  • The landscape of somatic copy-number alteration across human cancers

    Nature · 2010 · 10.1038/nature08822

  • Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1

    Nature · 2009 · 10.1038/nature08460

  • SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas

    Nature Genetics · 2009 · 10.1038/ng.465

  • Comprehensive genomic characterization defines human glioblastoma genes and core pathways

    Nature · 2008 · https://doi.org/10.1038/nature07385

  • Somatic mutations affect key pathways in lung adenocarcinoma

    Nature · 2008 · 10.1038/nature07423

  • High-throughput oncogene mutation profiling in human cancer

    Nature Genetics · 2007 · 10.1038/ng1975

  • Characterizing the cancer genome in lung adenocarcinoma

    Nature · 2007 · 10.1038/nature06358

  • Assessing the significance of chromosomal aberrations in cancer: Methodology and application to glioma

    Proceedings of the National Academy of Sciences · 2007 · 10.1073/pnas.0710052104

  • Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis

    Cancer Cell · 2005 · 10.1016/j.ccr.2005.03.023

  • EGFR Mutation and Resistance of Non–Small-Cell Lung Cancer to Gefitinib

    New England Journal of Medicine · 2005 · 10.1056/nejmoa044238

  • EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy

    Science · 2004 · https://doi.org/10.1126/science.1099314

  • Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses

    Proceedings of the National Academy of Sciences · 2001 · 10.1073/pnas.191502998

Current projects

    No projects listed.